Forsidebilde av showet The New GLP-1 Pill — No More Injections?

The New GLP-1 Pill — No More Injections?

Podkast av Inception Point AI

engelsk

Helse og personlig utvikling

Tidsbegrenset tilbud

2 Måneder for 19 kr

Deretter 99 kr / MånedAvslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Kom i gang

Les mer The New GLP-1 Pill — No More Injections?

Oral GLP-1 medications promise weight-loss results without needles, but can a daily pill with minimal absorption truly rival the proven power of weekly injections? Host Julia Cartwright unpacks the science, compares real-world trade-offs, and explores how new pricing models could finally make these drugs accessible to millions. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle episoder

8 Episoder

episode The New GLP-1 Pill — No More Injections? - Unpack the science changing weight loss forever with Julia Cartwright cover

The New GLP-1 Pill — No More Injections? - Unpack the science changing weight loss forever with Julia Cartwright

Join host Julia Cartwright as she explores the groundbreaking shift from GLP-1 injections to pills for weight loss. Discover how these oral medications work, their effectiveness versus shots, and what this needle-free option means for accessibility and cost. Perfect for anyone curious about weight management's future. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 32 s
episode The New GLP-1 Pill — No More Injections? - Can a Daily Tablet Replace Your Weekly Injection? cover

The New GLP-1 Pill — No More Injections? - Can a Daily Tablet Replace Your Weekly Injection?

Join AI host Julia Cartwright as she compares Foundayo, the FDA-approved daily GLP-1 pill, with injectable Wegovy. We examine clinical trial data showing Foundayo's 12.4% weight loss versus Wegovy's 15-16%, discuss medication adherence challenges, switching protocols, and explore who benefits most from each option in this evolving weight management landscape. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 25 min
episode The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution cover

The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution

Julia Cartwright explores how oral GLP-1 medications transformed obesity treatment access in 2026. Oral Wegovy and Foundayo launched at $25-$149 monthly, eliminating needles and cost barriers that kept 90% of eligible patients untreated. With 170,000 prescriptions in three weeks and home delivery options, the access revolution began reshaping healthcare for millions. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 30 min
episode The New GLP-1 Pill — No More Injections? - Needle-Free at Last, But Who Is This For? cover

The New GLP-1 Pill — No More Injections? - Needle-Free at Last, But Who Is This For?

Julia Cartwright explores Foundayo, the FDA-approved daily GLP-1 pill that offers a needle-free alternative for weight management. She examines who truly benefits from this $149/month medication—addressing barriers of cost, needle aversion, and accessibility that keep 90% of eligible patients untreated, while honestly comparing its effectiveness to injectable options. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 27 min
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Tidsbegrenset tilbud

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

2 Måneder for 19 kr
Deretter 99 kr / Måned

Kom i gang

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Ofte stilte spørsmål

Flere spørsmål og svar
Kom i gang

2 Måneder for 19 kr. Deretter 99 kr / Måned. Avslutt når som helst.